(2023) demonstrated that a PD-L1 antibody-expressing oncolytic virus (rgFlu/PD-L1) targets HCC cells by activating the cGAS-STING pathway, thereby enhancing CD8+ T cell function (136). This evidence concerns the gene CD274 and hepatocellular carcinoma.